fbpx
Completion of Patient Recruitment for SPIOMET4HEALTH Clinical Trials – Advancing PCOS Research Completion of Patient Recruitment for SPIOMET4HEALTH Clinical Trials SPIOMET4HEALTH has officially reached the completion of patient...
SPIOMET4HEALTH partners reunite to reflect and strategize for the future at General Assembly The SPIOMET4HEALTH partners, reunited! The project’s third General Assembly meeting took place in Barcelona, where we...
PARTICIPATE IN THE CLINICAL TRIAL TO EVALUATE THE FIRST TREATMENT FOR POLYCYSTIC OVARY SYNDROME (PCOS)

WHAT IS
SPIOMET4HEALTH

SPIOMET4HEALTH is a project that aims to provide a novel treatment for adolescent girls and young adult women with Polycystic Ovary Syndrome (PCOS). PCOS negatively affects the health and quality of life of approximately 110 million women who suffer from this syndrome, as well as their offspring. PCOS has an impact on the emotional, physical, social functioning and behaviour, and family-related activities.

Women with PCOS may have infrequent or prolonged menstrual periods or excessive levels of male hormones (androgens), which are usually present in women in small amounts. Those affected by the syndrome can also suffer from hirsutism, acne and abnormal body fat distribution, which in turn, tends to decrease self-confidence and self-esteem. Consequently, approximately 40% of women with PCOS are known to experience depression or anxiety.

SPIOMET4HEALTH's
solution

The SPIOMET4HEALTH project represents a potential treatment for PCOS that focuses on tackling the syndrome at its root, rather than merely relieving its symptoms.

This treatment combines three medications that have already proven to be effective in the past, in a single tablet. Combining SPI (spironolactone)-PIO (pioglitazone)-MET (metformin), SPIOMET, administered daily, together with lifestyle measures, could normalise ovulation and hormones, and thus revert the alterations associated to PCOS.

WHO CAN PARTICIPATE?

Age: 12-23.9 years
Age: 12-23.9 years
Irregular menstrual periods
Irregular menstrual periods
Excess body hair
Excess body hair
Work Packages FAQs about SPIOMET4HEALTH

LAST NEWS

PATIENT EXPERIENCES

My name is Emelyne, I am French and I am 33 years old.
My story with PCOS started early, as I was lucky enough to be diagnosed when I was 17 years old.

Besides not having my period, I had a myriad of symptoms such as weight gain, hair loss, and hirsutism (which was the start of a long battle). At first, I was blamed like many patients to secretly snack, and told that it was nothing and I just had to take the pill to regulate my symptoms.

PCOS had an effect on my life at an early age: unable to cope with all these symptoms, I stopped dancing and competing in gymnastics, which I loved very much. The thing is, back in 2005 there were not much resources and young patients like me were lost with the whole diagnosis.

Emelyne

33 years old. France.

I’m Alexandra, I’m 20 years old and I was diagnosed with PCOS at 14/15 years old.
It all started because I had very irregular menstruations and, whenever I had them, on the first day my ovaries would hurt a lot and my abdomen would swell. After some tests and analysis I was diagnosed with PCOS.

The most shocking thing for me was when the doctor told me that I might had trouble getting pregnant in the future. Throughout the visit I thought I was getting along…But when I got out of the car and arrived home I immediately started crying. It wasn’t only the problem of infertility, but also everything that living with this syndrome entailed: controlling weight, hair growth, my mood, etc.

Alexandra

20 years old. Spain.

“Since I was diagnosed with PCOS, I’ve never felt as well cared for as I do now, thanks to the Spiomet4health clinical trial”

Paula Romero is participating in the Spiomet4health clinical trial on Polycystic Ovary Syndrome (PCOS) at the Hospital Sant Joan de Déu (Barcelona, Spain).

She talks about her experience in the Spiomet4health clinical trial, in which she says she feels listened to and accompanied at all times by the professionals leading the study.

Paula

19 years old. Spain.

Go to top